ASTRIN BIOSCIENCES, INC.
Apheresis-based circulating tumor cell (CTC) isolation and analysis platform using holographic imaging and machine learning for metastatic prostate cancer precision medicine
- Sector
- Medtech
- Headquarters
- SAINT PAUL, MN
- Founded
- 2020
- Latest Form D
- $22.9M, Jun 2024
- Total capital
- $23.3M
- Federal grants
- $400K
- 1 award · 2022
- Rank in peer group#288 of 445
- Private capital raised
- $22.9M
- 1 Form D · last Jun 2024
- 28 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 36 pending · first 2024
- Rank in peer group#49 of 445
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$22.9M
- Federal grantHealth and Human S · Phase I · Development of a novel personalized medicine platform using apheretically isolated circulating tumor cells to assess drug responsiveness in prostate cancer$400K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
25months
from ASTRIN BIOSCIENCES, INC.’s first federal award to its first private round.
- First federal award · May 2022
- Health and Human S · $400K
- First Form D · Jun 2024
- $22.9M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 445 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#49 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- JAYANT PARTHASARATHYResearcherExecutive Officer, DirectorLinked by $400K in grants as PI
- ROBBIE HORWITZDirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 40- GrantedTrojan Circulating Tumor CellsUSPTOUS 12,728,140
- PendingTumor Cell Profiling-based Therapeutic Targeting Of CancerUSPTOApplication 19113971
- PendingPressure Balancing Across Microfluidic DevicesUSPTOApplication 19113966
Show all 40 patent records
- Trojan Circulating Tumor CellsSep 8, 2026 · US 12,728,140Granted
- Tumor Cell Profiling-based Therapeutic Targeting Of CancerApr 9, 2026 · Application 19113971Pending
- Pressure Balancing Across Microfluidic DevicesApr 9, 2026 · Application 19113966Pending
- Sawtooth Inertial DeviceApr 9, 2026 · Application 19113975Pending
- Aphaeretic Biopsy System Including Microfluidic DeviceMar 26, 2026 · Application 19113974Pending
- Label Free Cell SortingNov 11, 2025 · US 12,469,313Granted
- Feedback Controlled Microfluidic Piezoelectric Actuation Assembly And UseJul 24, 2025 · Application 18855526Pending
- Biological Fluid Filtration SystemMay 20, 2025 · US 12,303,896Granted
- Biological Fluid Filtration SystemDec 10, 2024 · US 12,162,010Granted
- Trojan Circulating Tumor CellsJul 11, 2024 · Application 18558318Pending
- Centrifuge Apheretic SystemJun 6, 2024 · Application 18062311Pending
- Hydro-cyclone Centrifuge Apheretic SystemJun 6, 2024 · Application 18062326Pending
- Biological Fluid Filtration SystemAug 19, 2021 · Application 17313369Pending
- Biological Fluid Filtration SystemAug 19, 2021 · Application 17313421Pending
- Biological Fluid Filtration SystemAug 5, 2021 · Application 17205508Pending
- Biological Fluid Filtration SystemAug 5, 2021 · Application 17205171Pending
- Biological Fluid Filtration SystemAug 5, 2021 · Application 17205769Pending
- Biological Fluid Filtration SystemAug 5, 2021 · Application 17205595Pending
- Biological Fluid Filtration SystemAug 5, 2021 · Application 17206271Pending
- Biological Fluid Filtration SystemAug 5, 2021 · Application 17162450Pending
- Biological Fluid Filtration SystemAug 5, 2021 · Application 17206231Pending
- Biological Fluid Filtration SystemAug 5, 2021 · Application 17206405Pending
- Biological Fluid Filtration SystemAug 5, 2021 · Application 17205338Pending
- Cancer Diagnostics Using Dual Imaging With Digital Inline HolographyApplication 63482913Pending
- Airblade Assisted Cell Dispensing SystemApplication 63482917Pending
- Tumor Cell Profiling-based Therapeutic Targeting Of CancerApplication 63408975Pending
- Pressure Balancing Across Microfluidic Devices In Separating Released Tumor Cells From A BloodstreamApplication 63408962Pending
- Sawtooth Inertial DeviceApplication 63408963Pending
- Multiplexed Targeted Peptide QuantitationApplication 63597682Pending
- Trojan Circulating Tumor CellsApplication PCTUS2022028101Pending
- Feedback Controlled Microfluidic Piezoelectric Actuation Assembly And UseApplication 63363422Pending
- Label Free Cell SortingApplication 63229175Pending
- Trojan Circulating Tumor CellsApplication 63184989Pending
- Biological Fluid Filtration SystemApplication PCTUS2021015945Pending
- Detection Using Dual Imaging With Digital Inline HolographyApplication 19152801Pending
- Multiplexed Targeted Peptide QuantitationApplication 19585575Pending
- Materials And Methods For Proteomic AnalysesApplication 19585581Pending
- Aphaeretic Biopsy System Including Microfluidic Devices To Separate Released Tumor Cells From A BloodstreamApplication 63408972Pending
- Early Cancer Detection Using Cell-free ProteomicsApplication PCTUS2025059019Pending
- Early Cancer Detection Using Cell-Free ProteomicsApplication 63910351Pending
Related companies, and why
- VERAVANTI INC.Similar federal contract value in Medtech · null in contracts
- Intabio, Inc.Similar federal contract value in Medtech · null in contracts
- Injectsense, Inc.Similar federal contract value in Medtech · null in contracts
- PACE DIAGNOSTICSSimilar federal contract value in Medtech · null in contracts
- Spark Neuro Inc.Similar federal contract value in Medtech · null in contracts
- ELM TREE MEDICAL INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .